Report ID: GIR2212290255 | Category: Pharma & Healthcare | Pages: 110 | Format: PDF | Published Date: February 07,2023
1 Market Overview 1.1 Product Overview and Scope of Pet Skin Disease Drugs 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Pet Skin Disease Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 Internal Medication 1.3.3 External Medication 1.4 Market Analysis by Application 1.4.1 Overview: Global Pet Skin Disease Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029 1.4.2 Parasitic Skin Diseases 1.4.3 Fungal Dermatoses 1.4.4 Bacterial Skin Diseases 1.4.5 Other 1.5 Global Pet Skin Disease Drugs Market Size & Forecast 1.5.1 Global Pet Skin Disease Drugs Consumption Value (2018 & 2022 & 2029) 1.5.2 Global Pet Skin Disease Drugs Sales Quantity (2018-2029) 1.5.3 Global Pet Skin Disease Drugs Average Price (2018-2029) 2 Manufacturers Profiles 2.1 Zoetis Animal Health 2.1.1 Zoetis Animal Health Details 2.1.2 Zoetis Animal Health Major Business 2.1.3 Zoetis Animal Health Pet Skin Disease Drugs Product and Services 2.1.4 Zoetis Animal Health Pet Skin Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.1.5 Zoetis Animal Health Recent Developments/Updates 2.2 Boehringer Ingelheim 2.2.1 Boehringer Ingelheim Details 2.2.2 Boehringer Ingelheim Major Business 2.2.3 Boehringer Ingelheim Pet Skin Disease Drugs Product and Services 2.2.4 Boehringer Ingelheim Pet Skin Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.2.5 Boehringer Ingelheim Recent Developments/Updates 2.3 Elanco 2.3.1 Elanco Details 2.3.2 Elanco Major Business 2.3.3 Elanco Pet Skin Disease Drugs Product and Services 2.3.4 Elanco Pet Skin Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.3.5 Elanco Recent Developments/Updates 2.4 Virbac 2.4.1 Virbac Details 2.4.2 Virbac Major Business 2.4.3 Virbac Pet Skin Disease Drugs Product and Services 2.4.4 Virbac Pet Skin Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.4.5 Virbac Recent Developments/Updates 2.5 Norbrook Laboratories 2.5.1 Norbrook Laboratories Details 2.5.2 Norbrook Laboratories Major Business 2.5.3 Norbrook Laboratories Pet Skin Disease Drugs Product and Services 2.5.4 Norbrook Laboratories Pet Skin Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.5.5 Norbrook Laboratories Recent Developments/Updates 2.6 Dechra Veterinary Products 2.6.1 Dechra Veterinary Products Details 2.6.2 Dechra Veterinary Products Major Business 2.6.3 Dechra Veterinary Products Pet Skin Disease Drugs Product and Services 2.6.4 Dechra Veterinary Products Pet Skin Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.6.5 Dechra Veterinary Products Recent Developments/Updates 2.7 Vetoquinol 2.7.1 Vetoquinol Details 2.7.2 Vetoquinol Major Business 2.7.3 Vetoquinol Pet Skin Disease Drugs Product and Services 2.7.4 Vetoquinol Pet Skin Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.7.5 Vetoquinol Recent Developments/Updates 2.8 ALKINLAB 2.8.1 ALKINLAB Details 2.8.2 ALKINLAB Major Business 2.8.3 ALKINLAB Pet Skin Disease Drugs Product and Services 2.8.4 ALKINLAB Pet Skin Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.8.5 ALKINLAB Recent Developments/Updates 2.9 Truseb 2.9.1 Truseb Details 2.9.2 Truseb Major Business 2.9.3 Truseb Pet Skin Disease Drugs Product and Services 2.9.4 Truseb Pet Skin Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.9.5 Truseb Recent Developments/Updates 2.10 Olewo 2.10.1 Olewo Details 2.10.2 Olewo Major Business 2.10.3 Olewo Pet Skin Disease Drugs Product and Services 2.10.4 Olewo Pet Skin Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.10.5 Olewo Recent Developments/Updates 2.11 KANGZHIBO 2.11.1 KANGZHIBO Details 2.11.2 KANGZHIBO Major Business 2.11.3 KANGZHIBO Pet Skin Disease Drugs Product and Services 2.11.4 KANGZHIBO Pet Skin Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.11.5 KANGZHIBO Recent Developments/Updates 2.12 Shanghai Hanvet Bio-Pharm 2.12.1 Shanghai Hanvet Bio-Pharm Details 2.12.2 Shanghai Hanvet Bio-Pharm Major Business 2.12.3 Shanghai Hanvet Bio-Pharm Pet Skin Disease Drugs Product and Services 2.12.4 Shanghai Hanvet Bio-Pharm Pet Skin Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.12.5 Shanghai Hanvet Bio-Pharm Recent Developments/Updates 2.13 DCVET 2.13.1 DCVET Details 2.13.2 DCVET Major Business 2.13.3 DCVET Pet Skin Disease Drugs Product and Services 2.13.4 DCVET Pet Skin Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.13.5 DCVET Recent Developments/Updates 2.14 Nanjing LANBOTO 2.14.1 Nanjing LANBOTO Details 2.14.2 Nanjing LANBOTO Major Business 2.14.3 Nanjing LANBOTO Pet Skin Disease Drugs Product and Services 2.14.4 Nanjing LANBOTO Pet Skin Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.14.5 Nanjing LANBOTO Recent Developments/Updates 2.15 Jindun Pharmaceutical 2.15.1 Jindun Pharmaceutical Details 2.15.2 Jindun Pharmaceutical Major Business 2.15.3 Jindun Pharmaceutical Pet Skin Disease Drugs Product and Services 2.15.4 Jindun Pharmaceutical Pet Skin Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.15.5 Jindun Pharmaceutical Recent Developments/Updates 3 Competitive Environment: Pet Skin Disease Drugs by Manufacturer 3.1 Global Pet Skin Disease Drugs Sales Quantity by Manufacturer (2018-2023) 3.2 Global Pet Skin Disease Drugs Revenue by Manufacturer (2018-2023) 3.3 Global Pet Skin Disease Drugs Average Price by Manufacturer (2018-2023) 3.4 Market Share Analysis (2022) 3.4.1 Producer Shipments of Pet Skin Disease Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022 3.4.2 Top 3 Pet Skin Disease Drugs Manufacturer Market Share in 2022 3.4.2 Top 6 Pet Skin Disease Drugs Manufacturer Market Share in 2022 3.5 Pet Skin Disease Drugs Market: Overall Company Footprint Analysis 3.5.1 Pet Skin Disease Drugs Market: Region Footprint 3.5.2 Pet Skin Disease Drugs Market: Company Product Type Footprint 3.5.3 Pet Skin Disease Drugs Market: Company Product Application Footprint 3.6 New Market Entrants and Barriers to Market Entry 3.7 Mergers, Acquisition, Agreements, and Collaborations 4 Consumption Analysis by Region 4.1 Global Pet Skin Disease Drugs Market Size by Region 4.1.1 Global Pet Skin Disease Drugs Sales Quantity by Region (2018-2029) 4.1.2 Global Pet Skin Disease Drugs Consumption Value by Region (2018-2029) 4.1.3 Global Pet Skin Disease Drugs Average Price by Region (2018-2029) 4.2 North America Pet Skin Disease Drugs Consumption Value (2018-2029) 4.3 Europe Pet Skin Disease Drugs Consumption Value (2018-2029) 4.4 Asia-Pacific Pet Skin Disease Drugs Consumption Value (2018-2029) 4.5 South America Pet Skin Disease Drugs Consumption Value (2018-2029) 4.6 Middle East and Africa Pet Skin Disease Drugs Consumption Value (2018-2029) 5 Market Segment by Type 5.1 Global Pet Skin Disease Drugs Sales Quantity by Type (2018-2029) 5.2 Global Pet Skin Disease Drugs Consumption Value by Type (2018-2029) 5.3 Global Pet Skin Disease Drugs Average Price by Type (2018-2029) 6 Market Segment by Application 6.1 Global Pet Skin Disease Drugs Sales Quantity by Application (2018-2029) 6.2 Global Pet Skin Disease Drugs Consumption Value by Application (2018-2029) 6.3 Global Pet Skin Disease Drugs Average Price by Application (2018-2029) 7 North America 7.1 North America Pet Skin Disease Drugs Sales Quantity by Type (2018-2029) 7.2 North America Pet Skin Disease Drugs Sales Quantity by Application (2018-2029) 7.3 North America Pet Skin Disease Drugs Market Size by Country 7.3.1 North America Pet Skin Disease Drugs Sales Quantity by Country (2018-2029) 7.3.2 North America Pet Skin Disease Drugs Consumption Value by Country (2018-2029) 7.3.3 United States Market Size and Forecast (2018-2029) 7.3.4 Canada Market Size and Forecast (2018-2029) 7.3.5 Mexico Market Size and Forecast (2018-2029) 8 Europe 8.1 Europe Pet Skin Disease Drugs Sales Quantity by Type (2018-2029) 8.2 Europe Pet Skin Disease Drugs Sales Quantity by Application (2018-2029) 8.3 Europe Pet Skin Disease Drugs Market Size by Country 8.3.1 Europe Pet Skin Disease Drugs Sales Quantity by Country (2018-2029) 8.3.2 Europe Pet Skin Disease Drugs Consumption Value by Country (2018-2029) 8.3.3 Germany Market Size and Forecast (2018-2029) 8.3.4 France Market Size and Forecast (2018-2029) 8.3.5 United Kingdom Market Size and Forecast (2018-2029) 8.3.6 Russia Market Size and Forecast (2018-2029) 8.3.7 Italy Market Size and Forecast (2018-2029) 9 Asia-Pacific 9.1 Asia-Pacific Pet Skin Disease Drugs Sales Quantity by Type (2018-2029) 9.2 Asia-Pacific Pet Skin Disease Drugs Sales Quantity by Application (2018-2029) 9.3 Asia-Pacific Pet Skin Disease Drugs Market Size by Region 9.3.1 Asia-Pacific Pet Skin Disease Drugs Sales Quantity by Region (2018-2029) 9.3.2 Asia-Pacific Pet Skin Disease Drugs Consumption Value by Region (2018-2029) 9.3.3 China Market Size and Forecast (2018-2029) 9.3.4 Japan Market Size and Forecast (2018-2029) 9.3.5 Korea Market Size and Forecast (2018-2029) 9.3.6 India Market Size and Forecast (2018-2029) 9.3.7 Southeast Asia Market Size and Forecast (2018-2029) 9.3.8 Australia Market Size and Forecast (2018-2029) 10 South America 10.1 South America Pet Skin Disease Drugs Sales Quantity by Type (2018-2029) 10.2 South America Pet Skin Disease Drugs Sales Quantity by Application (2018-2029) 10.3 South America Pet Skin Disease Drugs Market Size by Country 10.3.1 South America Pet Skin Disease Drugs Sales Quantity by Country (2018-2029) 10.3.2 South America Pet Skin Disease Drugs Consumption Value by Country (2018-2029) 10.3.3 Brazil Market Size and Forecast (2018-2029) 10.3.4 Argentina Market Size and Forecast (2018-2029) 11 Middle East & Africa 11.1 Middle East & Africa Pet Skin Disease Drugs Sales Quantity by Type (2018-2029) 11.2 Middle East & Africa Pet Skin Disease Drugs Sales Quantity by Application (2018-2029) 11.3 Middle East & Africa Pet Skin Disease Drugs Market Size by Country 11.3.1 Middle East & Africa Pet Skin Disease Drugs Sales Quantity by Country (2018-2029) 11.3.2 Middle East & Africa Pet Skin Disease Drugs Consumption Value by Country (2018-2029) 11.3.3 Turkey Market Size and Forecast (2018-2029) 11.3.4 Egypt Market Size and Forecast (2018-2029) 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029) 11.3.6 South Africa Market Size and Forecast (2018-2029) 12 Market Dynamics 12.1 Pet Skin Disease Drugs Market Drivers 12.2 Pet Skin Disease Drugs Market Restraints 12.3 Pet Skin Disease Drugs Trends Analysis 12.4 Porters Five Forces Analysis 12.4.1 Threat of New Entrants 12.4.2 Bargaining Power of Suppliers 12.4.3 Bargaining Power of Buyers 12.4.4 Threat of Substitutes 12.4.5 Competitive Rivalry 12.5 Influence of COVID-19 and Russia-Ukraine War 12.5.1 Influence of COVID-19 12.5.2 Influence of Russia-Ukraine War 13 Raw Material and Industry Chain 13.1 Raw Material of Pet Skin Disease Drugs and Key Manufacturers 13.2 Manufacturing Costs Percentage of Pet Skin Disease Drugs 13.3 Pet Skin Disease Drugs Production Process 13.4 Pet Skin Disease Drugs Industrial Chain 14 Shipments by Distribution Channel 14.1 Sales Channel 14.1.1 Direct to End-User 14.1.2 Distributors 14.2 Pet Skin Disease Drugs Typical Distributors 14.3 Pet Skin Disease Drugs Typical Customers 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology 16.2 Research Process and Data Source 16.3 Disclaimer
It contains all the geographic trends, and market analysis for global market